White Paper/Case Studies

  • Technically Speaking: An Innovative Approach to Cell Therapy Facility Design

    Cell therapy is a small but rapidly growing segment in biotechnology. This space has seen a large influx in investment by various small and large companies, primarily driven by the success seen in clinical trials for CAR-T therapies. In 2017, our industry saw the first BLA approval of a CAR-T drug by Novartis.

  • Achieving Biomanufacturing Success

    Successful biologic manufacturing requires highproductivity cell culture media that are easy and economical to prepare. Single-use mixers and filtration circuits can be an attractive option for achieving these goals, while also providing manufacturing flexibility.

  • The Real Costs of Outdated Printing Methods

    Fast-changing market needs and an aging population have tremendous repercussions for pharmaceutical and medical device companies, as well as for contract manufacturing organizations (CMOs). With worldwide demand for medicines on the rise, manufacturers and CMOs alike must package more and more medicines and devices while struggling to optimize their packaging line capacity and manage changeover times and downtime.

  • Investing In The Future of Freeze Drying for Biologic Drugs

    Biologic drugs are the fastest-growing class of therapeutic products in the United States. They are complex structures which place many difficult demands on manufacturing. Structural integrity is critical to the drug’s potency and preserving this during freeze-drying is challenging. Faithfully reproducing a freeze-drying cycle which stays within the design space for a given formulation is essential.

We use cookies to operate this website and to improve its usability. Full details of what cookies are, why we use them and how you can manage them can be found by reading our Privacy & Cookies page. Please note that by using this site you are consenting to the use of cookies.